# Bronwyn Le Grice

> Bronwyn Le Grice is the founder, CEO and Managing Director of ANDHealth, the Australian nonprofit she established in 2017 to support company commercialisation. A former BioScience Managers investment director and NZBIO chief executive, she led Adherium’s 2015 IPO project and has experience spanning capital raising, governance and industry advocacy. She is also a Lumos Diagnostics non-executive director and NHMRC Council member.

- **Role:** Founder, CEO and Managing Director at ANDHealth
- **Organizations:** ANDHealth, Lumos Diagnostics, National Health and Medical Research Council, BioScience Managers (former), Adherium (former), NZBIO (former), PetHomeStay (co-founder), Imagion Biosystems (former director), Neurosciences Victoria (former)
- **Nationality:** Australian
- **Education:** Bachelor of Commerce, University of Western Australia, Master of Commercial Law, Melbourne Law School, University of Melbourne, Professional Certificate in Commercialisation, University of Melbourne, Company Directors Course, Australian Institute of Company Directors, Company Directors Course, Institute of Directors in New Zealand
- **Known for:** Project-led the A$35 million Adherium IPO in 2015., Founded ANDHealth in 2017., Received the BioMelbourne Network Most Valuable Women in Leadership Award in 2020.

## Career timeline

- **Early career** — Worked with sporting teams, then moved from Western Australia to Melbourne and entered Neurosciences Victoria through a temporary executive assistant role.
- **2008–2011** — Chief Executive Officer of NZBIO in New Zealand.
- **2012** — Joined BioScience Managers as an Investment Director.
- **2015** — Project-managed Adherium’s A$35 million ASX IPO; also held commercial development and corporate affairs responsibilities.
- **2016** — Developed the concept for ANDHealth with James Dromey.
- **2017** — Founded ANDHealth with a consortium of industry partners.
- **2018** — Appointed a non-executive director of Imagion Biosystems, effective 26 April.
- **2019** — Completed a Master of Commercial Law at Melbourne Law School.
- **2020** — Joined the Lumos Diagnostics board; resigned from the Imagion Biosystems board on 31 March.
- **2021** — Became an NHMRC Council member and received the Victorian Pearcey Entrepreneur Award.
- **2024** — Reappointed to NHMRC Council for the 2024–2027 term.
- **2025** — Lumos annual report identified her as chair of the inaugural NHMRC-MRFF Industry, Philanthropy and Commercialisation Committee.

## Achievements

- Project-led the A$35 million Adherium IPO in 2015.
- Founded ANDHealth in 2017.
- Received the BioMelbourne Network Most Valuable Women in Leadership Award in 2020.
- Received the Victorian Pearcey Entrepreneur Award in 2021.
- One of 25 recipients of the 2022 Brilliant Women in Digital Health Awards.
- Led ANDHealth when its flagship program was nominated in the 2026 Prix Galien USA Best Incubators, Accelerators and Equity category.

## Latest updates

- **2026-09** — ANDHealth reported 104 applications for the latest ANDHealth+ intake, with selection of up to five companies and announcements expected in early 2027.
- **2026-08** — ANDHealth+ received a Prix Galien USA nomination in the Best Incubators, Accelerators and Equity category; the ceremony was scheduled for 29 October 2026.
- **2026-01** — Le Grice paid tribute to first employee Grace Lethlean as ANDHealth announced her transition away from a full-time executive role to an expert advisor connection.
- **2025-11** — ANDHealth’s annual-report announcement documented a A$33 million commitment to expand ANDHealth+ until 2030.

## Links

- Website: https://www.andhealth.com.au/
- LinkedIn: https://au.linkedin.com/in/bronwynlegrice
- Twitter/X: https://x.com/Bron_LeGrice

---

Profile page: https://yespress.io/bronwyn-le-grice
Published by YesPress — https://yespress.io
Last updated: 2026-10-22